Explore the words cloud of the DIDO-MS project. It provides you a very rough idea of what is the project "DIDO-MS" about.
The following table provides information about the project.
UNIVERSITA DEGLI STUDI DI PERUGIA
|Coordinator Country||Italy [IT]|
|Total cost||150˙000 €|
|EC max contribution||150˙000 € (100%)|
1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
|Duration (year-month-day)||from 2018-02-01 to 2019-07-31|
Take a look of project's partnership.
|1||UNIVERSITA DEGLI STUDI DI PERUGIA||IT (PERUGIA)||coordinator||150˙000.00|
Multiple sclerosis (MS) is a chronic and progressive neurodegenerative disease that is currently affecting 2.3 million people worldwide. Incidence rates of MS are significantly higher in Europe and in other regions located within the northern hemisphere. In Europe, the number of patients currently afflicted with MS is estimated to be at 700,000, with incidence rates ranging from 2.3-12.2/100,000 per year. GlobalData assessed the market value for MS treatments in 10 major markets (France, Germany, Italy, Spain, UK, US, Canada, Japan, China and India) in 2014 to be at €16.2 billion and predicts it to rise to approximately €18.82 billion by 2024. This increase is attributed to the projected sales of newly-approved drugs. The main shortcoming of current MS treatments ultimately lies in their lack of efficacy, specifically in that they are unable to prevent progressive neurodegeneration in MS patients. MS poses a significant economic burden on society as the disease affects primarily young people who are in their most economically-productive years. Aside from limited efficacies, current treatment options are also associated with severe side-effects (increased risks of infection, cancer), high costs and inconvenient administration routes (e.g. intravenous, intramuscular, subcutaneous). The aim of DIDO-MS is to assess the commercial viability of a newly identified small molecule as a drug in the treatment of MS.
|year||authors and title||journal||last update|
Marco Gargaro, Carmine Vacca, Serena Massari, Giulia Scalisi, Giorgia Manni, Giada Mondanelli, Emilia M. C. Mazza, Silvio Bicciato, Maria T. Pallotta, Ciriana Orabona, Maria L. Belladonna, Claudia Volpi, Roberta Bianchi, Davide Matino, Alberta Iacono, Eleonora Panfili, Elisa Proietti, Ioana Maria Iamandii, Violetta Cecchetti, Paolo Puccetti, Oriana Tabarrini, Francesca Fallarino, Ursula Grohmann
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells
published pages: , ISSN: 1664-3224, DOI: 10.3389/fimmu.2019.01973
|Frontiers in Immunology 10||2020-01-27|
Giada Mondanelli, Alberta Iacono, Massimo Allegrucci, Paolo Puccetti, Ursula Grohmann
Immunoregulatory Interplay Between Arginine and Tryptophan Metabolism in Health and Disease
published pages: 1565, ISSN: 1664-3224, DOI: 10.3389/fimmu.2019.01565
|Frontiers in Immunology 10||2020-01-27|
Claudia Volpi, Ciriana Orabona, Antonio Macchiarulo, Roberta Bianchi, Paolo Puccetti, Ursula Grohmann
Preclinical discovery and development of fingolimod for the treatment of multiple sclerosis
published pages: 1-14, ISSN: 1746-0441, DOI: 10.1080/17460441.2019.1646244
|Expert Opinion on Drug Discovery 7||2020-01-27|
Giada Mondanelli, Alberta Iacono, Agostinho Carvalho, Ciriana Orabona, Claudia Volpi, Maria T. Pallotta, Davide Matino, Susanna Esposito, Ursula Grohmann
Amino acid metabolism as drug target in autoimmune diseases
published pages: 334-348, ISSN: 1568-9972, DOI: 10.1016/j.autrev.2019.02.004
|Autoimmunity Reviews 18/4||2020-01-27|
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DIDO-MS" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "DIDO-MS" are provided by the European Opendata Portal: CORDIS opendata.
The Enemy of the Good: Towards a Theory of Moral ProgressRead More
Streamlined carbon dioxide conversion in ionic liquids – a platform strategy for modern carbonylation chemistryRead More
Towards Realistic Modelling of Nucleosome Organization Inside Functional Chromatin DomainsRead More